JP Morgan Chase
HQL

JP Morgan Chase’s abrdn Life Sciences Investors HQL Stock Holding History

JP Morgan Chase’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$32 – 7885
2026
Q1 		$32 Buy
+2
New +$33 ﹤0.01% 7387
2025
Q2 		– Sell
-5
Closed -$63 – 7333
2025
Q1 		$63 Buy
+5
New +$68 ﹤0.01% 6939
2024
Q4 		– Sell
-2
Closed -$30 – 7536
2024
Q3 		$30 Hold
2
– – ﹤0.01% 7200
2024
Q2 		$28 Hold
2
– – ﹤0.01% 7123
2024
Q1 		$27 Sell
2
-8,103
-100% -$112K ﹤0.01% 7129
2023
Q4 		$109K Buy
8,105
+8,104
+810,400% +$99.7K ﹤0.01% 5698
2023
Q3 		$12 Sell
1
-20,710
-100% -$272K ﹤0.01% 7264
2023
Q2 		$280K Buy
20,711
+20,709
+1,035,450% +$286K ﹤0.01% 4870
2023
Q1 		$0 Buy
2
+1
+100% +$14 ﹤0.01% 6942
2022
Q4 		$0 Buy
+1
New +$14 ﹤0.01% 6743
2022
Q2 		– Sell
-4
Closed – – 6646
2022
Q1 		$0 Hold
4
– – ﹤0.01% 6779
2021
Q4 		$0 Buy
4
+3
+300% +$60 ﹤0.01% 6781
2021
Q3 		$0 Buy
+1
New +$21 ﹤0.01% 6626
2021
Q2 		– Sell
-3
Closed – – 6448
2021
Q1 		$0 Buy
3
+2
+200% +$41 ﹤0.01% 6183
2020
Q4 		$0 Sell
1
-1
-50% -$18 ﹤0.01% 5753
2020
Q3 		$0 Hold
2
– – ﹤0.01% 5593
2020
Q2 		$0 Buy
+2
New +$34 ﹤0.01% 5514
2019
Q4 		– Sell
-2
Closed – – 5728
2019
Q3 		$0 Buy
2
+1
+100% +$16 ﹤0.01% 5832
2019
Q2 		$0 Hold
1
– – ﹤0.01% 5857
2019
Q1 		$0 Buy
+1
New +$17 ﹤0.01% 5893
2017
Q1 		– Sell
-20
Closed – – 5127
2016
Q4 		$0 Buy
+20
New +$351 ﹤0.01% 5056
2016
Q2 		– Sell
-11
Closed – – 4860
2016
Q1 		$0 Buy
+11
New +$200 ﹤0.01% 4794
2014
Q1 		– Sell
-26,510
Closed -$542K – 3731
2013
Q4 		$542K Buy
+26,510
New +$514K ﹤0.01% 3451

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

JP Morgan Chase's HQL Position: Q2 2026 in Review

JP Morgan Chase sold out of abrdn Life Sciences Investors (HQL) in Q2 2026, closing a stake of 2 shares — an estimated $32 sold.

JP Morgan Chase first reported a position in HQL in Q4 2013 and held it in 23 quarters. The position peaked at $542K in Q4 2013. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • JP Morgan Chase reported no remaining abrdn Life Sciences Investors position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 2 abrdn Life Sciences Investors shares in Q2 2026, an estimated $32.
  • JP Morgan Chase first reported a position in abrdn Life Sciences Investors in Q4 2013 and held it in 23 quarters.
  • JP Morgan Chase's abrdn Life Sciences Investors position peaked at $542K in Q4 2013.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.